Helicobacter pylori risk in type 2 diabetes mellitus: a hospital based case-control study
DOI:
https://doi.org/10.18203/2349-2902.isj20174508Keywords:
Dyspeptic symptoms, Endoscopic biopsy, H pylori, Non-diabetics, Type II diabetes mellitusAbstract
Background: The aim of this study is to determine the frequency of Helicobacter pylori (H. pylori) infection in Type 2 diabetic and non-diabetic patients with dyspeptic symptoms and to compare the frequency of H. pylori infection in both groups.
Methods: This was a hospital-based case-control study was conducted on 196 subjects in the Department of General Surgery, Saveetha Medical College and Hospital (tertiary care hospital) from March 2016 to November 2016. Patients were divided into two groups i.e. type 2 diabetics with poor glycemic control with dyspeptic symptoms and non-diabetics with dyspeptic symptoms. Each group consisted of 98 patients. All type 2 diabetic patients of ≥35 years of age with poor glycemic control both gender and the known cases with history of dyspepsia, epigastric pain or bloating for more than a month were screened for helicobacter pylori infection. The collected data of both groups was evaluated and separated for analysis
Results: Majority of the patients were male with mean age±SD, 50±12. Among the type II diabetic group with dyspeptic symptoms, H. pylori was positive in 70/98 (71.4%), whereas in non-diabetic group with dyspeptic symptoms H. pylori was positive in 51/98 (52%) cases.
Conclusion: Type II diabetic patients with dyspeptic symptoms are more prone and at risk to acquire H. pylori infection. Therefore, proper monitoring of blood glucose level and screening for H. pylori infection are effective preventive measures for this chronic infection.
References
Bener A, Micallef R, Afifi M, Derbala M, Al-Mulla HM, Usmani MA. Association between type 2 diabetes mellitus and Helicobacter pylori infection. Turk J Gastroenterol. 2007;18:225-9.
Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther. 1995;9:33-9.
Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev. 1997;10:720-41.
Demir M, Gokturk HS, Ozturk NA, Kulaksizoglu M, Serin E, Yilmaz U. Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycaemic control and late complications. Dig Dis Sci. 2008;53:2646-9.
Zuman R. Prevalence of Helicobacter pylori in relation to promotive factor among human urban population of Bahawalpur district Pakistan. Pak J Biol Sci. 2006;9:2636-41.
Engelgau MM. Diabetes diagnostic criteria and impaired glycemic states: evolving evidence base. Clin Diabetes. 2004;22:69-70.
Romano M, Cuomo A. Eradication of Helicobacter pylori: a clinical update. Med Gen Med. 2004;6:16-20.
Ojetti V, Migneco A, Silveri NG, Ghirlanda G, Gasbarrini G, Gasbarrini A. The role of H. pylori infection in Diabetes. Curr Diabetes Rev. 2005;1:343-7.
Marrollo M, Latella G, Melideo D, Storelli E, Iannarelli R, Stornellip, et al. Increased prevalence of Helicobacter pylori in patients with diabetes mellitus. Dig Liver Dis. 2001;33:21-9.
Ugwu N, Ugwuja E, Ejikeme B, Obeka N. Helicobacter pylori seropostivity in Nigerians with Type 2 Diabetes mellitus. Internet J Trop Med. 2008;4:32-6.
Sargyn M, Uygur-Bayramicli O, Sargyn H, Orbay E, Yavuzer D, Yayla A. Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori. World J Gastroenterol. 2003;9:1126-8.
De Martel C, Parsonnet J. Helicobacter pylori infection and gender: a meta-analysis of population- based prevalence surveys. Dig Dis Sci. 2006;51:2292-301.
Kanbay M, Gür G, Arslan H, Yilmaz U, Boyacioglu S. The relationship of ABO blood group, age, gender, smoking and Helicobacter pylori infection. Dig Dis Sci. 2005;50:1214-7.
WU MS, Lee WJ, Wang HH, Huang SP, Lin JT. A case-controlled study of association of Helicobacter pylori infection with morbid obesity in Taiwan. Arch Intern Med. 2005;165:1552-5.
Yamagata H, Kiyohara Y, Nakamura S, Kubo M, Tanizaki Y, Matsumoto T, et al. Impact of fasting plasma glucose levels on gastric cancer incidence in a general Japanese population. The Hisayama Study. Diabetes Care. 2005;28:789-94.
